Tags

Type your tag names separated by a space and hit enter

Patient-reported autonomic symptoms in Parkinson disease.
Neurology. 2007 Jul 24; 69(4):333-41.Neur

Abstract

OBJECTIVE

There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD), but the full spectrum has never been evaluated with a validated instrument and in comparison with control subjects. In this study a reliable and valid instrument, the SCOPA-AUT, was used to evaluate the occurrence of AS in a large cohort of patients with PD and control subjects and to assess the relations with demographic, disease-related, and clinical variables.

METHODS

A cohort of 420 patients with PD was evaluated for the occurrence of AS, motor and nonmotor symptoms, as well as for demographic and disease-related characteristics. Results were compared with those of 150 control subjects. Associations between AS and demographic and clinical characteristics were also studied.

RESULTS

For all autonomic domains, patients with PD reported more symptoms compared to control subjects, with the greatest differences in the gastrointestinal and urinary domain. Higher age, greater disease severity, and higher doses of dopaminergic medication were related to more autonomic problems. Autonomic symptom severity was associated with more motor dysfunction, depressive symptoms, cognitive dysfunction, psychiatric complications, nighttime sleep disturbances, and excessive daytime sleepiness (all p values < 0.01).

CONCLUSIONS

Autonomic symptoms (AS) are an important feature of Parkinson disease (PD) and increase with age, disease severity, and medication use. The prominent presence of AS warrants increased clinical awareness and highlights the need for efficacious therapies for the wide spectrum of problems related to this domain of PD.

Authors+Show Affiliations

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. D.Verbaan@lumc.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17646625

Citation

Verbaan, D, et al. "Patient-reported Autonomic Symptoms in Parkinson Disease." Neurology, vol. 69, no. 4, 2007, pp. 333-41.
Verbaan D, Marinus J, Visser M, et al. Patient-reported autonomic symptoms in Parkinson disease. Neurology. 2007;69(4):333-41.
Verbaan, D., Marinus, J., Visser, M., van Rooden, S. M., Stiggelbout, A. M., & van Hilten, J. J. (2007). Patient-reported autonomic symptoms in Parkinson disease. Neurology, 69(4), 333-41.
Verbaan D, et al. Patient-reported Autonomic Symptoms in Parkinson Disease. Neurology. 2007 Jul 24;69(4):333-41. PubMed PMID: 17646625.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Patient-reported autonomic symptoms in Parkinson disease. AU - Verbaan,D, AU - Marinus,J, AU - Visser,M, AU - van Rooden,S M, AU - Stiggelbout,A M, AU - van Hilten,J J, PY - 2007/7/25/pubmed PY - 2007/8/21/medline PY - 2007/7/25/entrez SP - 333 EP - 41 JF - Neurology JO - Neurology VL - 69 IS - 4 N2 - OBJECTIVE: There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD), but the full spectrum has never been evaluated with a validated instrument and in comparison with control subjects. In this study a reliable and valid instrument, the SCOPA-AUT, was used to evaluate the occurrence of AS in a large cohort of patients with PD and control subjects and to assess the relations with demographic, disease-related, and clinical variables. METHODS: A cohort of 420 patients with PD was evaluated for the occurrence of AS, motor and nonmotor symptoms, as well as for demographic and disease-related characteristics. Results were compared with those of 150 control subjects. Associations between AS and demographic and clinical characteristics were also studied. RESULTS: For all autonomic domains, patients with PD reported more symptoms compared to control subjects, with the greatest differences in the gastrointestinal and urinary domain. Higher age, greater disease severity, and higher doses of dopaminergic medication were related to more autonomic problems. Autonomic symptom severity was associated with more motor dysfunction, depressive symptoms, cognitive dysfunction, psychiatric complications, nighttime sleep disturbances, and excessive daytime sleepiness (all p values < 0.01). CONCLUSIONS: Autonomic symptoms (AS) are an important feature of Parkinson disease (PD) and increase with age, disease severity, and medication use. The prominent presence of AS warrants increased clinical awareness and highlights the need for efficacious therapies for the wide spectrum of problems related to this domain of PD. SN - 1526-632X UR - https://www.unboundmedicine.com/medline/citation/17646625/Patient_reported_autonomic_symptoms_in_Parkinson_disease_ L2 - http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=17646625 DB - PRIME DP - Unbound Medicine ER -